GM Vs Tesla: How Do Q1 EV Sales Stack Up?

General Motors Co (NYSE:GM) posted first-quarter sales of over 20,000 EVs in the U.S. What Happened: General Motors…

General Motors Co (NYSE:GM) posted first-quarter sales of over 20,000 EVs in the U.S.

What Happened: General Motors sold over 20,000 EVs in a quarter for the first time in the first quarter of 2023, the company said in a statement. The sales were mostly spurred by Chevrolet Bolt EVs and EUVs.

The company sold a total of 603,208 vehicles in the U.S. in the first quarter, marking an increase of 18%. Meanwhile, market share rose by an estimated 1.5 points.

Sales growth was reported across brands; Buick sales jumped 99%, Chevrolet sales rose 16%, Cadillac sales by 29%, and GMC by 8%.

See Also: Best Stock Trading Software

As for the future quarters, the Detroit-based automaker reiterated its production guidance. General Motors is on track to build 50,000 EVs in North America through June and double that in the second half, the company said.

Rival and EV giant Tesla Inc (NASDAQ:TSLA) on Sunday reported a 36.39% year-over-year increase in deliveries to 422,875 units, beating analyst estimates.

Price Action: Shares of General Motors rose 0.1% in extended trading after closing 0.03% higher at $36.28, according to data from Benzinga Pro.

Check out more of Benzinga’s Future Of Mobility coverage by following this link.

Read More: Tesla Vs GM Vs Rivian: Who Gained The Most Market Share In Q1?

Total
0
Shares
Related Posts
Read More

Castle Biosciences Announces Results From A Randomized Controlled Trial Show That TissueCypher Barrett’s Esophagus Test Results Can Significantly Improve The Accuracy Of Risk Assessments And Adherence To Guideline-recommended Patient Management

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced new data from a randomized controlled trial (RCT) showing that use of TissueCypher®

CSTL